BIOGEN INC. Logo

BIOGEN INC.

Biotechnology company developing therapies for neurological and neurodegenerative diseases.

BIIB | US

Overview

Corporate Details

ISIN(s):
US09062X1037
LEI:
Country:
United States of America
Address:
225 BINNEY STREET, 2142 CAMBRIDGE

Description

Biogen Inc. is a global biotechnology company focused on discovering, developing, and delivering innovative therapies for people with serious neurological and neurodegenerative diseases. Founded in 1978, the company leverages cutting-edge science to address complex and hard-to-treat conditions. Its core therapeutic areas include multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, and amyotrophic lateral sclerosis. In addition to its portfolio of novel drugs, Biogen also develops and commercializes biosimilars. The company's pipeline is concentrated on potential breakthrough treatments in neurology, immunology, and rare diseases, aiming to address significant unmet medical needs and improve patient outcomes worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-03 17:42
PRIMARY DOCUMENT
English 7.3 KB
2025-11-13 21:28 English 8.6 KB
2025-11-04 17:12
PRIMARY DOCUMENT
English 7.1 KB
2025-10-30 07:31
10-Q
English 4.8 MB
2025-10-30 07:13
8-K
English 185.6 KB
2025-10-14 18:19
8-K
English 80.9 KB
2025-10-06 15:00
PRIMARY DOCUMENT
English 7.0 KB
2025-09-02 19:56
PRIMARY DOCUMENT
English 7.3 KB
2025-09-02 14:54 English 7.0 KB
2025-07-31 08:13
8-K
English 177.3 KB
2025-07-31 08:05
10-Q
English 4.7 MB
2025-07-30 19:56 English 8.3 KB
2025-07-21 23:18 English 9.8 KB
2025-07-16 19:55
PRIMARY DOCUMENT
English 6.5 KB
2025-07-08 17:26 English 6.9 KB

Automate Your Workflow. Get a real-time feed of all BIOGEN INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOGEN INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOGEN INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.